6168 related articles for article (PubMed ID: 3264757)
1. [Effect of recombinant interleukin 2 on peripheral blood lymphocytes in vitro. IV. Cytotoxicity of lymphocytes in patients with malignant tumors].
Jíra M; Strejcek J; Faltýn J; Chodounský Z; Suchomelová M; Tomásová M; Zábojová E; Procházka M
Cas Lek Cesk; 1988 Nov; 127(46):1422-4. PubMed ID: 3264757
[No Abstract] [Full Text] [Related]
2. [The effect of in vitro interleukin 2 on lymphocytes and monocytes in human peripheral blood. I. Induction of proliferation and cytotoxicity].
Jíra M; Strejcek J; Antosová E; Horký J
Cas Lek Cesk; 1986 Dec; 125(51):1573-7. PubMed ID: 3492272
[No Abstract] [Full Text] [Related]
3. Interleukin 2 activation of cytotoxic T-lymphocytes infiltrating into human metastatic melanomas.
Itoh K; Tilden AB; Balch CM
Cancer Res; 1986 Jun; 46(6):3011-7. PubMed ID: 3486040
[TBL] [Abstract][Full Text] [Related]
4. Effects of human recombinant interleukin 2 on in vitro tumor cytotoxicity in dogs.
Raskin RE; Holcomb CS; Maxwell AK
Am J Vet Res; 1991 Dec; 52(12):2029-32. PubMed ID: 1789517
[TBL] [Abstract][Full Text] [Related]
5. Basic study on immunologic effects of cyclosporine and FK 506 for application to pancreatic transplantation.
Takaori K; Inoue K; Nio Y; Aung T; Fukumoto M; Hashida T; Yasuhara M; Hori R; Tobe T
Transplant Proc; 1992 Jun; 24(3):894-6. PubMed ID: 1376531
[No Abstract] [Full Text] [Related]
6. Efficient generation of autologous peripheral blood-derived cytotoxic T lymphocytes against poorly immunogenic human tumors using recombinant CD80-adenovirus together with interleukin 12 and interleukin 2.
Mogi S; Ebata T; Setoguchi Y; Fujime M; Heike Y; Kohsaka T; Yagita H; Okumura K; Azuma M
Clin Cancer Res; 1998 Mar; 4(3):713-20. PubMed ID: 9533541
[TBL] [Abstract][Full Text] [Related]
7. [The response of peripheral blood lymphocytes from lung cancer patients to in-vitro treatment with recombinant interleukin-2].
Pogodina ON; Karaseva NA; Ivanov VA
Tsitologiia; 1997; 39(7):582-9. PubMed ID: 9490499
[TBL] [Abstract][Full Text] [Related]
8. The interaction of IL-2 and IL-4 with the effects of deoxyspergualin.
Kerr PG; Atkins RC
Transplant Proc; 1990 Oct; 22(5):2121-2. PubMed ID: 2219316
[No Abstract] [Full Text] [Related]
9. [Modulation with phorbol myristate acetate and staurosporine of interleukin 2- induced proliferation and nonspecific cytotoxicity of rat lymphocytes].
Anisimov AG; Bolotnikov IA
Biull Eksp Biol Med; 1996 Oct; 122(10):394-8. PubMed ID: 9081434
[No Abstract] [Full Text] [Related]
10. IL-4 inhibits IL-2 induction of LAK cytotoxicity in lymphocytes from a variety of lymphoid tissues.
Colquhoun SD; Economou JS; Shau H; Golub SH
J Surg Res; 1993 Nov; 55(5):486-92. PubMed ID: 8231167
[TBL] [Abstract][Full Text] [Related]
11. Reactivity of peripheral blood lymphocytes to recombinant interleukin-2 in kidney transplant recipients.
Koda N; Oda T; Yokoyama M; Matsumoto A; Takeuchi M
Transplant Proc; 1990 Oct; 22(5):2373-5. PubMed ID: 2219405
[No Abstract] [Full Text] [Related]
12. Cytokine combinations for induction of antigen-specific cytolytic T lymphocytes from peripheral blood lymphocytes.
Tsujitani S; Nakashima M; Watanabe T; Kaibara N; Koprowski H; Steplewski Z
Anticancer Res; 1995; 15(3):655-60. PubMed ID: 7645938
[TBL] [Abstract][Full Text] [Related]
13. In vivo and in vitro activation of NK cytotoxicity with IL-2.
Ibayashi Y; Tokuda Y; Saks ER; Sarna GP; Golub SH
Prog Clin Biol Res; 1987; 244():275-85. PubMed ID: 3498954
[No Abstract] [Full Text] [Related]
14. Phenotypical and functional differences of tumor-infiltrating lymphocytes from human colorectal cancers induced by costimulation with rIL-2 and rIL-4 in vitro.
Keller H; Wimmenauer S; Rahner S; Von Kleist S; Farthmann EH
Anticancer Res; 1996; 16(6B):3565-70. PubMed ID: 9042222
[TBL] [Abstract][Full Text] [Related]
15. Alteration of lymphocyte microtubule assembly, cytotoxicity, and activation by the anticancer drug taxol.
Chuang LT; Lotzová E; Heath J; Cook KR; Munkarah A; Morris M; Wharton JT
Cancer Res; 1994 Mar; 54(5):1286-91. PubMed ID: 7907000
[TBL] [Abstract][Full Text] [Related]
16. Expansion of tumor-infiltrating lymphocytes from human solid tumors in interleukin-2.
Whiteside TL; Heo DS; Chen K; Adler A; Johnson JT; Herberman RB
Prog Clin Biol Res; 1987; 244():213-22. PubMed ID: 3309998
[No Abstract] [Full Text] [Related]
17. Morphological changes of lymphocytes activated with interleukin-2.
Nano R; Barni S; Capelli E
Haematologica; 1996; 81(1):93-4. PubMed ID: 8900858
[No Abstract] [Full Text] [Related]
18. Ergot alkaloid-induced cell proliferation, cytotoxicity, and lymphokine production.
Fiserová A; Trinchieri G; Chan S; Bezouska K; Flieger M; Pospisil M
Adv Exp Med Biol; 1995; 371A():163-6. PubMed ID: 8525898
[No Abstract] [Full Text] [Related]
19. Effect of human recombinant interleukin-2 on cytotoxic response of peripheral blood mononuclear cells in melanoma patients before surgery.
Jira M; Strejcek J; Chodounsky Z; Fuchsova M; Tomasova M; Faltyn J; Suchomelova M
Arch Geschwulstforsch; 1987; 57(5):379-84. PubMed ID: 3500690
[TBL] [Abstract][Full Text] [Related]
20. [The effect of interleukin-2 on peripheral lymphocytes and monocytes. III. Proliferative and cytotoxic effects in vitro in patients with systemic erythematosus and progressive polyarthritis].
Jíra M; Strejcek J; Zavadil Z; Antosová E; Rejholec V
Cas Lek Cesk; 1988 Dec; 127(52):1609-12. PubMed ID: 3265892
[No Abstract] [Full Text] [Related]
[Next] [New Search]
